Recommend which initiatives to continue, re-assess or stop


Deciding which R&D initiatives to continue, review, or close usually means going through each one's health status, budget variance, and schedule by hand. That process can miss initiatives that have quietly stalled with no spend against them.
Hand the first pass to Prism. Ask it to assess the portfolio, and it reads health status, phase, end date, and budget variance on each initiative, then sorts each into continue, re-assess, or stop, with the reason behind each call stated directly.
Required inputs
Continue these (3 of ~40 shown)
| Initiative | Key reason |
|---|---|
| ProVision Series: Integrated Premium Professional Monitor Platform | On track, TRL 6, flagship for ISE 2029 |
| Solid-State Battery Integration for Grid Storage | On track, transformational, no budget variance flagged |
| Quantum-Safe Cryptography Migration Roadmap | On track, 0% variance |
Re-assess these (3 of ~30 shown)
| Initiative | Key reason |
|---|---|
| Smart EV Charging Infrastructure Management | Critical, +22% effective overrun, largest in portfolio |
| AI-Powered Patent Landscape Analysis Tool | Challenging, +11.8% variance |
| NIS2 Compliance Documentation Automation | Critical, zero spend against a mandatory regulatory deadline |
Stop these (3 of ~30 shown)
| Initiative | Key reason |
|---|---|
| Digital Thread from Design to Shop Floor | Critical, +13.7% variance, highest in portfolio |
| Smart Street Lighting with 5G Small Cells | Critical, €1M spent against a €12M plan |
| Waste Heat Recovery ORC System for Plants | Critical, over 20 months overdue |
Priority actions: two Re-assess initiatives are flagged for immediate escalation over cost overruns. Roughly 15 of the Stop initiatives show zero spend against an expired deadline and are recommended for formal closure to free governance capacity.
Follow-up prompts: